Search results
Is Biogen (BIIB) an Underappreciated Stock?
Insider Monkey via Yahoo Finance Canada· 1 day agoPatient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” second quarter 2024 investor letter. A...
Sage Shares Fall After Drug Fails in Essential Tremor Study
Bloomberg· 1 day agoSage Therapeutics Inc. plunged after a mid-stage study of its drug to treat essential tremor failed,...
Biogen and Sage to scrap neurological disorder drug development after trial failure
AOL· 1 day agoThe experimental drug, SAGE-324, was being studied as a treatment for essential tremor, a disorder that causes uncontrollable shaking of the hands, arms and other body parts. The drug failed ...
Global biosimilar market estimated to reach a size of $43.8 billion by the end of 2024
BioPharma-Reporter· 1 day agoThe biosimilars market is rapidly growing as global demand for biosimilars continues to grow....
Health Care: Q2 lobbying boost
Axios· 2 days agoAn affiliated company also named in the legislation, WuXi Biologics, spent $125,000 in Q2. Among the big Q2 spenders listing the Biosecure Act as an issue were Amgen ($2.7 million),
Living Security Makes Its Human Risk Management Conference 2024 Available on Demand
Digital Journal· 2 days agoAUSTIN, TX / ACCESSWIRE / July 23, 2024 / Nearly two dozen experts on the front lines of cybersecurity provided their insight and advice at Living Security's third annual Human Risk Management ...
